Company Overview
More
Shenzhen Hypri Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company with business in heparin sodium preparation and API, macromolecular drug contract development and production organization (CDMO) and innovative drug development. The company's main products and services include enoxaparin sodium preparations and heparin sodium raw materials, enoxaparin sodium raw materials, and macromolecular drug CDMO services. The company's products are sold in the domestic market and overseas markets, including Turkey, Brazil and the United States.
CEO： Li Li
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Moomoo > Quotes > 09989 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. > Financial Statement > Balance sheet
09989 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
6.330+0.040+0.64%
YOY
Do not show
(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Assets
Current assets
Inventory
47.21%
5.06B
48.59%
4.71B
24.36%
4.16B
21.53%
3.61B
Accounts receivable
27.48%
1.65B
-8.46%
1.53B
22.3%
1.62B
7.26%
1.71B
Notes receivable
-57.33%
7.69M
--
--
-69.46%
10.75M
--
--
Related party payments receivable
--
--
-10.45%
44.09M
--
--
-38.55%
48.12M
Insurance and other receivables-current assets
48.84%
226.92M
--
--
233.32%
251.38M
--
--
Advance deposits and other receivables
--
--
-18.77%
566.69M
--
--
-11.83%
762.29M
Cash and equivalents
6.96%
3.47B
11.23%
1.48B
28.22%
3.75B
41.91%
1.85B
Fixed time deposit-current assets
--
--
5.23%
1.44B
--
--
--
1.52B
Secured deposit
--
--
14376.25%
11.58M
--
--
-79.05%
10.81M
Financial assets at fair value-current assets
--
--
19.44%
980.91M
--
--
16349.23%
643.82M
Derivative financial instruments-current assets
--
--
-96.43%
248K
--
--
-83.3%
1.91M
Other current assets
-23.64%
178.96M
--
--
42.75%
256.32M
--
--
Special items of current assets
-38.2%
988.61M
-26.78%
14.99M
-43.49%
397.69M
-20.54%
20.29M
Total current assets
15.59%
11.84B
17.99%
10.77B
20.95%
10.7B
47.38%
10.18B
Non-current assets
Fixed assets
-7.44%
1.95B
--
--
-0.64%
2.01B
--
--
Property, plant and equipment
--
--
-3.69%
2.53B
--
--
-4.38%
2.57B
Construction in progress
15.88%
437.77M
--
--
-15.4%
440.2M
--
--
Long-term receivables
-28.11%
1.82M
--
--
--
2.18M
--
--
Development expenditure
160.88%
41.44M
--
--
96.6%
28.95M
--
--
Associated company interest
--
--
-29.72%
1.15B
--
--
6.57%
1.53B
long-term investment
-32.32%
1.11B
--
--
-6.43%
1.49B
--
--
Financial assets at fair value-non-current assets
--
--
-42.97%
996.5M
--
--
-32.74%
867.7M
Intangible assets
-11.86%
531.26M
-7.69%
472.97M
-9.14%
568.32M
-10.05%
491.79M
Goodwill
-3.4%
2.14B
-2.29%
2.15B
-4.77%
2.19B
-8.75%
2.18B
Deferred tax assets
77.36%
122M
45.01%
121.72M
-42.79%
70.76M
-36.94%
75.62M
Other illiquid assets
1.79%
1.24B
-28.98%
206.02M
-31.94%
1.08B
-34.12%
207.04M
Special items of non-current assets
27.77%
241.23M
-11.34%
714.74M
-18.76%
176.03M
-1.98%
878.7M
Total non-current assets
-9.39%
8.29B
-15.76%
8.34B
-11.4%
8.56B
-9.08%
8.8B
Total assets
3.81%
20.13B
0.43%
19.11B
4.07%
19.27B
14.42%
18.98B
Liabilities
Current liabilities
Accounts payable
68.07%
537.89M
61.27%
385.79M
115.74%
361.57M
64.26%
382.63M
Tax payable
57.44%
159.61M
50.99%
113M
135.53%
185.09M
35.81%
160.02M
Dividend payable
--
--
--
--
--
--
-1.96%
220.09M
Amounts payable to associated parties-current liabilities
--
--
-23.3%
6.22M
--
--
297.8%
7.06M
Other payables and accrued expenses
20.11%
367.28M
15.7%
608.73M
-5.46%
300.38M
-8.21%
471.28M
Short-term borrowing
3.43%
2.33B
--
--
12.85%
1.9B
--
--
Bank loans and overdrafts
--
--
31.68%
3.27B
--
--
-41.51%
1.96B
Financial lease liabilities-current liabilities
--
--
24.04%
31.75M
--
--
-29.55%
23.47M
Other current liabilities
55.21%
4.29M
--
--
-88.2%
3.19M
--
--
Special items of current liabilities
417.91%
1.96B
47.04%
377.81M
-40.84%
676.96M
35.17%
387.75M
Total current liabilities
55.7%
5.73B
32.62%
4.79B
4.45%
3.91B
-24.14%
3.61B
Net current assets
-6.9%
6.11B
8.4%
5.98B
33.05%
6.79B
206.42%
6.56B
Total assets less current liabilities
-8.35%
14.4B
-7.11%
14.32B
3.97%
15.36B
29.96%
15.36B
Non-current liabilities
Long-term bank loan
-20.18%
1.24B
-27.08%
2.25B
11.16%
1.46B
-9.99%
3.1B
Long-term accounts payable
21.85%
311.85K
--
--
24.53%
283.89K
--
--
Long-term remuneration payable to staff and workers
-11.53%
137.05M
5.41%
138.02M
23.6%
134.86M
21.07%
131.21M
Financial lease liabilities-non-current liabilities
--
--
101.38%
104M
--
--
-38.52%
45.59M
Deferred tax liability
-36.6%
275.39M
-35.61%
275.36M
-1.12%
310.49M
8.96%
316.63M
Deferred income-non-current liabilities
-0.08%
18.21M
-11.05%
16.67M
-10.75%
17.19M
-10.48%
17.71M
Issued debt instrument
--
863.36M
--
--
-0.1%
1.56B
--
--
Other non-current liabilities
--
--
-1.61%
9.07M
--
--
-8%
9.16M
Special items of non-current liabilities
-93.56%
110.16M
--
--
-35.95%
53.33M
--
--
Total non-current liabilities
-31.69%
2.64B
-24.99%
2.79B
3.98%
3.53B
-8.28%
3.62B
Total liabilities
10.91%
8.38B
3.38%
7.58B
4.23%
7.44B
-16.95%
7.23B
Total assets less total liabilities
-0.71%
11.75B
-1.42%
11.52B
3.96%
11.82B
49.13%
11.74B
Total equity and non-current liabilities
-8.35%
14.4B
-7.11%
14.32B
3.97%
15.36B
29.96%
15.36B
Equity
Share capital
0%
1.47B
0%
1.47B
0%
1.47B
17.65%
1.47B
Reserve
--
--
-1.56%
9.94B
--
--
56.14%
10.16B
Legal reserve
0%
536.8M
-1.56%
9.94B
0.86%
536.8M
56.14%
10.16B
Capital reserve
-1.5%
5.94B
--
--
0.45%
5.98B
--
--
Undistributed profit
1.66%
3.88B
--
--
14.98%
3.87B
--
--
Special items of shareholders' rights and interests
-37.3%
-188.42M
--
--
-125.23%
-142.01M
--
--
Shareholders' Equity
-0.67%
11.64B
-1.37%
11.41B
4.06%
11.71B
49.95%
11.62B
Non-controlling interest
-5.18%
112.79M
-6.39%
111.96M
-4.65%
115.13M
-3.26%
117.85M
Total equity
-0.71%
11.75B
-1.42%
11.52B
3.96%
11.82B
49.13%
11.74B
Total equity and total liabilities
3.81%
20.13B
0.43%
19.11B
4.07%
19.27B
14.42%
18.98B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)IASCAS (2007)IAS
Audit Opinions
--Unqualified Opinion----
Auditor
--Ernst & Young accounting firm----
Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%